In contrast to many other transfection reagents, the efficiency of jetPRIME® is increased when used in the presence of serum. The complexes can therefore be added directly to the cells in serum-containing medium
None of our products transfection efficiency is affected by the presence of antibiotics. For example, the routine validation protocol for each new batch of jetPRIME® is always performed in serum and antibiotics containing medium.
Cell density will affect transfection performance. For optimal transfection with jetPRIME®, we recommend transfecting cells at 60% to 80% confluency. Please refer to Table 1 in the jetPRIME® transfection protocol for the recommended number of cells to seed according to the culture plate format. In addition, if cells have been in culture for a long time (over 20 passages), we recommend starting a new culture with a fresh tube of cells from liquid nitrogen.
Passage numbers will affect transfection performance. If cells have been in culture for a long time (over 20 passages), transfection will decrease and we recommend starting a new culture with a fresh tube of cells from liquid nitrogen. On the other hand, cells should be passaged at least 2 times after thawing before using them in transfection experiments.
For cotransfection of multiple plasmids, the total DNA amount per well should not exceed the DNA amount indicated in the protocol. The ratio to use for each plasmid depends on the size of the plasmid, the plasmid construct and the expected expression level (of each plasmid). Each plasmid should represent at least 10% of the total DNA amount per well.
Transfection is quite a traumatic event for the cells. In order to improve cell viability, find below several suggestions:
– change the medium 4h after transfection
– decrease the DNA amount
– decrease the volume of jetPRIME®
– perform transfection in serum-containing medium
– analyze the transfection efficiency 24 h after transfection instead of 48 h
– ensure that jetPRIME® and DNA are diluted into the jetPRIME® buffer
– check if the plasmid is endotoxin free
jetPRIME® is the reagent of choice for virus production in classical medium as detailed here. Indeed, transfection efficiency using jetPRIME® reaches up to 90% in cells commonly used for virus production, such as HEK-293 and derivatives, CHO, VERO, WOP and BHK cells, hence leading to high viral titers (Dewannieux, M., Vernochet, C., Ribet, D., Bartosch, B., Cosset, F. L., Heidmann, T. (2011). The mouse IAPE endogenous retrovirus can infect cells through any of the five GPI-anchored Ephrin A proteins., PLoS Pathog 7, e1002).
We usually recommend using INTERFERin® or jetPEI®, depending on the size of the oligonucleotides. jetPRIME® is not the reagent of choice for ODN transfection. Please contact the technical support if you wish to perform ODN transfection (contact us).
INTERFERin® is the reagent of choice for siRNA transfection, and works with as little as 1 nM siRNA. jetPRIME® is aso perfectly suitable for siRNA transfection, using 10 to 50 nM siRNA final concentration.
Suspension cells, such as T and B lymphocytes, are notoriously hard to transfect cells with DNA, whatever the chemical reagent used. Hence we usually recommend using electroporation or virus transduction for nucleic acid delivery into suspension cells.
Vegetal cells have a cellulose rich-membrane that prevents jetPRIME®/DNA complexes entering the cells. Even at the protoplasts stage where the cellulose envelope has been removed, complexes are not able to penetrate into the cytoplasm.
For HUVEC cells, we recommend using jetPEI®-HUVEC, a reagent specifically designed for this purpose as described here.
RAW 264.7 are successfully transfected with DNA using jetPRIME®. A transfection efficiency of 50% can be achieved following the standard conditions. For DNA transfection into primary macrophages or monocyte/dendritic cell-derived macrophages, jetPEI®-macrophage is the reagent of choice. Please click here for more information concerning a wide variety of cells.
jetPRIME® is a novel proprietary cationic polymer-based molecule, synthesized at Polyplus-transfection.
jetPRIME® forms positively charged complexes with DNA. These complexes then penetrate the cell through endocytosis. Endosomes then release DNA in the cytosol via the proton sponge mechanism. The plasmid mostly reaches the nucleus when the nuclear envelope disappears during mitosis.
jetPRIME® is a very stable molecule. jetPRIME® and its buffer are shipped at room temperature and should be stored at 4°C to ensure long term stability.
jetPRIME® is a very stable molecule. Experiments were conducted in house to test the stability of the jetPRIME® reagent. After 48 hours at 50°C, jetPRIME® shows a similar transfection efficiency as if stored at 4°C.
jetPRIME® can undergo an accidental freeze/thaw cycle without compromising the transfection efficiency. However, for long term storage we recommend storing the reagent at 4°C to ensure long term stability.
jetPRIME® cat#114-01 (0.1 ml) is stable for 6 months. Other pack sizes of jetPRIME® are stable for at least one year, when stored appropriately.
The ratio gives the number of microliters of jetPRIME® to use per microgram of DNA. For example, a 1:2 DNA to jetPRIME® ratio means 2 µl jetPRIME® per µg DNA.
The first step of optimization is to increase the DNA amount up to 1.5 fold. We also recommend increasing the DNA to jetPRIME® ratio (2 to 3 µl jetPRIME® per µg DNA). Another method consists in gentle centrifugation of the culture plate (5 min at 210 g).
The protocol provided with jetPRIME® has been optimized for a large variety of cell lines such as A549, MCF7, U-2 OS, NIH-3T3, B16-F10, Caco-2… However specific protocols have been developed for specific cell lines in order to achieve a higher efficiency. These specific conditions can be viewed in the Polyplus-transfection Database.
jetPRIME® is very efficient for DNA transfection onto HEK-293 and HeLa cells. Hence, we recommend decreasing the DNA amount (from 1 µg to 0.5 µg per well for a 6 well plate for example), and using a 1:2 DNA to jetPRIME® ratio.
There is no size restriction for DNA transfection using jetPRIME®. However, keep in mind that for the same amount of DNA, the gene copy number will be less for large DNA than for smaller plasmids.
Please feel free to browse the Polyplus-transfection Database, in which specific conditions for many cells may be found.
INTERFERin® is a new generation of non liposomal cationic amphiphile transfection reagent. It was developed for the delivery of siRNA into mammalian cells in culture. INTERFERin® provides more than 90% silencing efficiency at 1 nM siRNA.
INTERFERin® has been successfully used on various adherent and non-adherent cell lines such as HeLa, HEK-293, A549, MDA-MB-231, BHK-21, CHO and OVCAR-3. INTERFERin® has also been used on several primary cells such as primary human fibroblast and primary human hepatocytes. For more details, please refer to the Polyplus-transfection Database.
Several types of molecules are abusively called miRNA. The term miRNA can refer to:
– mimic miRNA: these are structurally similar but not identical to siRNA and can be transfected with INTERFERin®.
– plasmid encoding for miRNA: this can be transfected using jetPRIME®.
– antimiR: this is a single-stranded nucleic acid designed to specifically bind to and inhibit endogenous microRNA; it can be transfected using INTERFERin®.
INTERFERin® should be stored tightly capped at 4°C.
INTERFERin® should not be frozen, as this strongly compromises its efficiency. We recommend discarding the frozen tube and using a new one.
INTERFERin® cat#409-01 (0.1 ml) is stable for 6 months. Other pack sizes of INTERFERin® are stable for at least one year, when stored appropriately
PULSin® contains a cationic amphiphile molecule capable of forming complexes with many proteins, including antibodies or peptides, resulting in a positively charged coat. These PULSin®/proteins complexes bind to syndecans, a molecule presents in virtually all cells membrane, allowing entry in the cell and subsequent escape of the protein from the endosome to the cytoplasm.
Established cell lines from various types such as HeLa and NIH-3T3, suspension cells such as Jurkat and primary cells such as human keratinocytes have all been successfully tested for PULSIN®-mediated delivery of r-phycoerythrin, the positive control protein included in the kit (for an exhaustive list please refer to the Polyplus-transfection Database).
Negatively charged protein at physiological pH (protein with pI ranging from 0 to 7.4) with size ranging from 40 to 250 KDa have been successfully delivered using PULSin®. Moreover, various antibodies recognizing different cell components such as anti-giantin, anti-vimentin and anti-tubulin have also been successfully delivered still recognising their target. Peptides have also been successfully delivered (for details please refer to PULSin® page).
Antibodies, proteins or peptides delivered with PULSin® are transported to the cytoplasm of the cell where it is released from the PULSin®/protein complexes. Proteins < 50kDa should be able to diffuse to the nucleus. For nuclear targeting of larger proteins, the proteins need to carry a nuclear localization signal (NLS).
PULSin® should not be frozen, as this strongly compromises its efficiency. We recommend discarding the frozen tube and using a new one.
jetPEI® (for in vitro use) and in vivo-jetPEI® are based on the same active molecule, however they have been specifically developed for each application. Thus they differ in formulation, concentration, purity and validation tests (in vivo-jetPEI® has been tested for absence of endotoxin and validated for in vivo gene delivery in mice).
in vivo-jetPEI® is very stable and shipped at room temperature. However, for long-term conservation, we recommend storing in vivo-jetPEI® at -20°C upon reception.
Different types of nucleic acids have been successfully delivered using in vivo-jetPEI®: DNA, siRNA, mimic miRNA, antimiR, oligonucleotides… Please refer to the Polyplus-transfection Database.
in vivo-jetPEI® has been tested in many species such as mice, rats, mosquitoes, shrimps, guinea pigs, macaques… Please feel to contact the technical support for more information (contact us).
In vivo-jetPEI® is suitable for systemic and local nucleic acid delivery. Several ways of administration have been successfully tested such as intravenous injection (tail vein and retroorbital), intraperitoneal injection, intratumoral injection, intracerebral injection, intranasal instillation, as detailed in the Application note Publications by Administration route.
In vivo-jetPEI® is the reagent of choice for nucleic acid delivery to the lung. Indeed, the lung is the most targeted organ following systemic delivery of in vivo-jetPEI®/nucleic acid complexes.
The delivery procedure highly depends on the organ to target. Depending on the route of administration, in vivo-jetPEI®-mediated gene expression was observed in the brain, liver, pancreas, spleen, kidney, heart, bladder, skin, retina, etc. Please contact our technical support team for more advice (contact us).
jetPEI® transfection reagent is particularly well suited for automated or manual HTS with three protocols available: reverse, batch and forward. jetPEI® provides highly reproducible results and the DNA/jetPEI® complexes are stable for up to 4 hours. Please click here for more information.
INTERFERin®-HTS is a new generation siRNA transfection reagent especially developed for HTS applications providing great silencing efficiency, excellent reproducibility and high cell viability with very low amounts of reagent. INTERFERin®-HTS is cost-effective, easy to handle, compatible with serum and antibiotics, and comes with reverse and forward protocols for 96- and 384-well plates, as described here.
INTERFERin®-HTS is not the reagent of choice for standard siRNA applications. Please choose INTERFERin® siRNA Tranfection Reagent for day-to-day transfections.
jetPEI® is composed of a linear polyethylenimine (PEI) whose molecular weight is proprietary information. Extensive optimization experiments have been performed in order to select the linear PEI giving the optimal DNA delivery with the most reduced toxicity in vitro.
jetPEI® can be used for other applications than HTS such as in vitro DNA transfection. In addition Polyplus-transfection developed a specific protocol for jetPEI®-mediated DNA transfection into primary neurons. Please contact the technical support team for more information (contact us).
FectoPRO® is perfectly well suited for virus production in suspension cells. PEIpro® is better suited for virus production in adherent cells and is provided with extensive QCs, making it suitable for therapeutic virus production.
FectoPRO® and PEIpro® can both be used for biomanufacturing. FectoPRO® is particularly suited to achieve very high protein yields in CHO or HEK-293 growing in suspension. But for large or very-large scale experiments, you might want to use PEIpro® as it is also very efficient in HEK-293 cells and more economical.
FectoPRO® can be used without FectoPRO® booster, but it is recommended if you want to achieve high protein yields using low DNA amounts.
FectoPRO® can undergo an accidental freeze/thaw cycle without compromising the transfection efficiency. However, for long term storage we recommend storing the reagent at 4°C to ensure long term stability.
PEIpro® is composed of a linear polyethylenimine (PEI) whose molecular weight is proprietary information. Extensive optimization experiments have been performed in order to select the linear PEI giving the optimal DNA delivery with the most reduced toxicity in vitro.
PEIpro® is provided as an aqueous solution of highly pure and qualified linear PEI at a concentration of 1 mg/L
PEIpro® can undergo an accidental freeze/thaw cycle without compromising the transfection efficiency. However, for long term storage we recommend storing the reagent at 4°C to ensure long term stability.
Cells known as hard to transfect usually correspond to primary cells or cell lines that have slow to non dividing rates. While viral transduction constitutes a useful alternative to DNA transfection, there are several limiting factors including potential safety hazard, low titer production and higher risk of genomic integration. Therefore, we have developed an efficient non viral alternative based on messenger RNA (mRNA) delivery to outperform DNA transfection in a wide variety of cells.
The success of mRNA delivery is mainly due to circumventing the need for nuclear import of DNA, hindered in slow to none dividing cells. Therefore, by switching to mRNA transfection, cells that are slow dividing or that have developed specific mechanisms to protect their genome can finally be used for gene expression, with unmatched transfection efficiencies.
jetMESSENGER™’s protocol is simple: the reagent is ready-to-use and is compatible with the standard growth media (with or without serum and antibiotics) of a wide variety of adherent and suspension cell lines. jetMESSENGER™ operates through a very gentle process and upholds cell viability and overall cellular morphology in a variety of hard to transfect cells, such as rat cortex neurons, human liver carcinoma cells and mouse embryonic stem cells.
mRNA can be produced using commercially available solutions (e.g. HiScribe kit provided by New England Biolabs) or be purchased “custom made” through different oligonucleotide suppliers such as Trilink, Eurofins or Aldevron.
mRNA is synthesized from DNA templates such as plasmid DNA, PCR product, synthetic oligonucleotides. Importantly, the template must be linearized and contain a RNA polymerase promoter region such as T7 or SP6 upstream of the sequence to be transcribed, in 5’ for the sense RNA or in 3’ for the antisense RNA. If required, the RNA polymerase promoter region can be added upstream of the sequence to be transcribed by PCR using primers containing the minimal promoter sequences.
There is no limit in mRNA size per se. It is worth to keep in mind that mRNA synthesis kits are usually optimized for mRNA transcripts ranging in size from 0.3 to 5kb, equivalent to a protein size of 10-150 kDa. Therefore, for shorter or longer mRNA transcripts, additional optimization may be required to obtain a similar high yield.
During the synthesis of endogenous eukaryotic mRNA, a 7-methylguanosine CAP is added in 5’ on the nascent transcript to protect it from degradation and increase translation rate. The presence of a polyA-tail in 3’ of nascent mRNA further protects from degradation and plays a role in the nuclear export of the mature mRNA. Therefore, existing mRNA synthesis kits usually offer solutions to improve stability of mRNAs by incorporation of 5’ cap analog, and 3’ polyA-tail. In addition, specific base modification within the mRNA sequence such as 5-methylcytosine and/or N6-methyladenine can be incorporated for stability and immunogenicity purposes. Custom-made mRNA ordered from an oligonucleotide provider can be ordered with specific modifications such as Pseudo-Uridine for increased stability.
Increasing the stability of the RNA transcript may not always be necessary. For example, some viral RNA transcripts do not need to be capped and polyadenylated in order to start replicating and/or produce infectious virus after transfection.
In comparison to DNA transfection, mRNA-mediated transfection with jetMESSENGER™ enables a more controlled gene expression that is not promoter dependent, over a similar period of time. In actively dividing cells, mRNA expression will be more prominently and stably observed between 1 to 4 days post-transfection. In slow to non-dividing cells, mRNA expression can be stable over a longer period of time, as for example up to 7 days in primary neuronal cells.
mRNA delivery is suited for transient expression, but not for the generation of stable clones. mRNA cannot integrate into the cell genome, which prohibits the generation of stable clones but has the advantage of not modifying the genome of the host cell.
Please feel free to browse the Polyplus-transfection Database, in which specific conditions for many hard to transfect cells may be found.
mRNA transfection is perfectly suited for primary cells, including primary neuronal cell types, stem cells, immune cells and fibroblasts.
jetMESSENGER mRNA transfection reagent is particularly well suited for transfection of cells grown in suspension such as Jurkat cells.
jetMESSENGER™ mRNA transfection reagent can be used with two protocols: reverse and forward. In the forward protocol, the cells are split the day before transfection and the jetMESSENGER™/mRNA complexes are added to the cells. Conversely, in the reverse protocol, mRNA/jetMESSENGER complexes are first deposited in the wells prior to addition of the cells. The full protocol is available in our Resources section.
mRNA transfection is not only suited for difficult to transfect cells, but can also be used to transfect fast dividing and usually known as easy to transfect cells. Moreover, mRNA transfection with jetMESSENGER is suited for both adherent and suspension cell lines and primary cells.
Lower amounts of mRNA and reagent in comparison to DNA transfection with L2K are required to perform transfection using jetMESSENGER™. Typically, per well of a 6-well plate, 2 ug of mRNA is complexed with a volume of 4 ul of jetMESSENGER™ reagent, whereas up to 2.5 ug of DNA with 5-12.5 ul of L2K are recommended.
A free trial pack size of 0.1 ml of jetMESSENGER™ mRNA transfection reagent is available upon request and is sufficient to perform at least 25 transfections in 6-well plates.